نتایج جستجو برای: alk

تعداد نتایج: 5774  

2015
Jeeyun Lee Hee Cheol Kim Jung Yong Hong Kai Wang Sun Young Kim Jiryeon Jang Seung Tae Kim Joon Oh Park Ho Yeong Lim Won Ki Kang Young Suk Park Jiyun Lee Woo Yong Lee Yoon Ah Park Jung Wook Huh Seong Hyeon Yun In-Gu Do Seok Hyung Kim Sohail Balasubramanian Philip J. Stephens Jeffrey S. Ross Gang Gary Li Zachary Hornby Siraj M. Ali Vincent A. Miller Kyoung-Mee Kim Sai-Hong Ignatius Ou

PURPOSE Anaplastic lymphoma kinase (ALK) rearrangement has been detected in colorectal carcinoma (CRC) using advanced molecular diagnostics tests including exon scanning, fluorescence in situ hybridization (FISH), and next generation sequencing (NGS). We investigated if immunohistochemistry (IHC) can be used to detect ALK rearrangement in gastrointestinal malignancies. EXPERIMENTAL DESIGNS Ti...

2013
Pablo Martinez Javier Hernández-Losa Susana Cedrés Josep Castellví Alex Martinez-Marti Natalia Tallada Nuria Murtra-Garrell Alejandro Navarro-Mendivill Victor Rodriguez-Freixinos Mercedes Canela Santiago Ramon y Cajal Enriqueta Felip

BACKGROUND Anaplastic Lymphoma Kinase (ALK) positivity represents a novel molecular target in a subset of Non-Small Cell Lung Cancers (NSCLC). We explore Fluorescence in situ Hybridization (FISH) and Immunohistochemistry (IHC) as diagnostic methods for ALK positive patients and to describe its prevalence and outcomes in a population of NSCLC patients. METHODS NSCLC patients previously screene...

2016
Joachim T. Siaw Haiying Wan Kathrin Pfeifer Victor M. Rivera Jikui Guan Ruth H. Palmer Bengt Hallberg

Anaplastic lymphoma kinase (ALK) is a tyrosine kinase receptor which has been implicated in numerous solid and hematologic cancers. ALK mutations are reported in about 5-7% of neuroblastoma cases but the ALK-positive percentage increases significantly in the relapsed patient population. Crizotinib, the first clinically approved ALK inhibitor for the treatment of ALK-positive lung cancer has had...

2013
Damini Chand Yasuo Yamazaki Kristina Ruuth Christina Schönherr Tommy Martinsson Per Kogner Edward F. Attiyeh John Maris Olena Morozova Marco A. Marra Miki Ohira Akira Nakagawara Per-Erik Sandström Ruth H. Palmer Bengt Hallberg

Neuroblastoma is a childhood extracranial solid tumour that is associated with a number of genetic changes. Included in these genetic alterations are mutations in the kinase domain of the anaplastic lymphoma kinase (ALK) receptor tyrosine kinase (RTK), which have been found in both somatic and familial neuroblastoma. In order to treat patients accordingly requires characterisation of these muta...

Journal: :Blood 1999
B Falini K Pulford A Pucciarini A Carbone C De Wolf-Peeters J Cordell M Fizzotti A Santucci P G Pelicci S Pileri E Campo G Ott G Delsol D Y Mason

The tumor cells in ALK-positive lymphoma ("ALKoma") usually express the product of the NPM-ALK chimeric gene, generated by the t(2;5) chromosomal translocation. However, 10% to 20% of ALK-positive lymphomas express ALK fusion protein(s) other than NPM-ALK, and in this report, we describe the immunohistologic and clinicopathologic features of 15 such cases. The absence of the NPM-ALK fusion gene...

Journal: :Gaceta Mexicana de Oncología 2022

El linfoma anaplasico de celulas grandes (LACG) es un tipo no Hodgkin (LNH) caracterizado por presentar neoplasicas que son CD30+. La clasificacion las neoplasias linfoides la Organizacion Mundial Salud (OMS) 2016 incluye el LACG ALK+, ALK– y asociado a implantes mamarios. presenta caracteristicas pronosticas clinicas diferentes entre los casos positivos negativos ALK. Los ALK-1+ comunmente se ...

2013
Savitri Krishnamurthy Wendy Woodward Wei Yang James M Reuben James Tepperberg Dai Ogura Shin-ichiro Niwa Lei Huo Yun Gong Randa El-Zein Ana M Gonzalez-Angulo Mariana Chavez-MacGregor Ricardo Alvarez Anthony Lucci Vicente Valero Naoto T Ueno

BACKGROUND Although preliminary reports suggest that ALK gene amplification may occur in inflammatory breast cancer (IBC), data are limited. We performed a comprehensive investigation of the status of ALK gene in IBC. METHODS We used core biopsy (CB) samples from 30 IBC patients for immunohistochemistry (IHC), 25 of these samples for fluorescence in situ hybridization (FISH) of ALK gene rearr...

2003
Mihaela Onciu Frederick G. Behm James R. Downing Sheila A. Shurtleff Susana C. Raimondi Zhigui Ma Stephan W. Morris Wren Kennedy Sandra C. Jones John T. Sandlund

2 ABSTRACT While most ALK-positive Non-Hodgkin lymphomas (NHL) are of T-cell lineage, a small number of B-lineage tumors with plasmablastic morphology and expression of the full-length ALK protein have been described in the literature. All of these reported tumors lacked the NPM-ALK fusion transcript. There is controversy regarding the existence of ALK fusion-positive B-cell NHL, many investiga...

Journal: :Blood 2006
Mohamad Fawal Florence Armstrong Severine Ollier Henri Dupont Christian Touriol Bernard Monsarrat Georges Delsol Bernard Payrastre Dominique Morello

Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) is a chimeric protein expressed in a subset of cases of anaplastic large cell lymphoma (ALCL) for which constitutive expression represents a key oncogenic event. The ALK signaling pathway is complex and probably involves functional redundancy between various signaling substrates of ALK. Despite numerous studies on signaling mediators, the molec...

2014
JUN AKIBA AKIHIKO KAWAHARA HIDEYUKI ABE KOICHI AZUMA TOMOHIKO YAMAGUCHI TOMOKI TAIRA CHIHIRO FUKUMITSU YORIHIKO TAKASE MAKIKO YASUMOTO YUMI UMENO KEITA TODOROKI TAKASHI KURITA RIN YAMAGUCHI MASAYOSHI KAGE HIROHISA YANO

Rearrangements of anaplastic lymphoma kinase (ALK) have been recently identified in non-small cell lung carcinomas. Previous studies have revealed characteristic features, including adenocarcinoma histology and mucin production, in ALK-positive lung carcinoma. The present study evaluated immunohistochemistry (IHC) in ALK-positive lung carcinoma using two different antibodies, clone 5A4 and D5F3...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید